The present invention relates to compounds of the formula ##STR00001##
which are useful in treating diseases characterized by the hyperactivity
of MEK. Accordingly the compounds are useful in the treatment of
diseases, such as, cancer, cognative and CNS disorders and
inflammatory/autoimmune diseases.